Petros Pharmaceuticals, Inc. Gain (Loss) on Disposition of Assets
Petros Pharmaceuticals, Inc. (PTPI) reported Gain (Loss) on Disposition of Assets of $6.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-13
- Petros Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00.
- Petros Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- Petros Pharmaceuticals, Inc. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was $6.97M.
- Petros Pharmaceuticals, Inc. gain (loss) on disposition of assets for fiscal 2025 was $6.97M.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $6.97M derived: sum of 3 quarters · filed 2026-08-13 | $6.97M 10-K · filed 2026-04-15 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $6.97M derived: sum of 2 quarters · filed 2026-08-13 | $6.97M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.97M 10-Q · filed 2026-08-13 | $6.97M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |